The role of biomechanics and inflammation in cartilage injury and repair

Clinical Orthopaedics and Related Research

Volumn 423, Issue , 2004, Pages 17-26

  Guilak, Farshid ^a,b   Fermor, Beverley ^a   Keefe, Francis J ^a   Kraus, Virginia B ^a   Olson, Steven A ^a   Pisetsky, David S ^a,c   Setton, Lori A ^a,b   Weinberg, J Brice ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NITRIC OXIDE; PROSTAGLANDIN E2;

ARTICULAR CARTILAGE; BIOMECHANICS; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL VIABILITY; CONFERENCE PAPER; DISEASE COURSE; IN VIVO STUDY; INFLAMMATION; JOINT FRACTURE; JOINT INJURY; JOINT STABILITY; MEDIATOR RELEASE; METABOLIC REGULATION; NONHUMAN; OBESITY; OSTEOARTHRITIS; PATHOGENESIS; POSTTRAUMATIC OSTEOARTHRITIS; PRIORITY JOURNAL; RISK FACTOR; TISSUE REPAIR;

EID: 2942731600     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000131233.83640.91     Document Type: Conference Paper

References (158)

1. Abramson SB: The role of COX-2 produced by cartilage in arthritis. Osteoarthritis Cartilage 7:380-381, 1999.
2. Altman RD, Tenenbaum J, Latta L, et al: Biomechanical and biochemical properties of dog cartilage in experimentally induced osteoarthritis. Ann Rheum Dis 43:83-90, 1984.
3. Amin AR, Di Cesare PE, Vyas P, et al: The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 182:2097-2102, 1995.
4. Amin AR, Vyas P, Attur M, et al: The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase. Proc Natl Acad Sci U S A 92:7926-7930, 1995.
5. Anderson DD, Bell AL, Gaffney MB, Imbriglia JE: Contact stress distributions in malreduced intraarticular distal radius fractures. J Orthop Trauma 10:331-337, 1996.
6. Anderson GD, Hauser SD, McGarity KL, et al: Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin-6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679, 1996.
7. Anonymous: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update: American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43:1905-1915, 2000.
8. Ateshian GA, Lai WM, Zhu WB, Mow VC: An asymptotic solution for the contact of two biphasic cartilage layers. J Biomech 27:1347-1360, 1994.
9. Attur MG, Patel IR, Patel RN, Abramson SB, Amin AR: Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians 110:65-72, 1998.
10. Baratz ME, Des Jardins J, Anderson DD, Imbriglia JE: Displaced intra-articular fractures of the distal radius: The effect of fracture displacement on contact stresses in a cadaver model. J Hand Surg 21A:185-188, 1996.
11. Beckman JS, Crow JP: Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21:330-334, 1993.
12. Blanco FJ, Lotz M: IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 218:319-325, 1995.
13. Bombardieri S, Cattani P, Giabattoni G, et al: The synovial prostaglandin system in chronic inflammatory arthritis: Differential effects of steroidal and non-steroidal antiinflammatory drugs. Br J Pharmacol 73:893-901, 1981.
14. Bonassar LJ, Grodzinsky AJ, Srinivasan A, Davila SG, Trippel SB: Mechanical and physicochemical regulation of the action of insulin-like growth factor-1 on articular cartilage. Arch Biochem Biophys 379:57-63, 2000.
15. Brandt KD, Doherty M, Lohmander LS: Osteoarthritis. New York, Oxford University Press, 1998.
16. Brown TD, Anderson DD, Nepola JV, et al: Contact stress aberrations following imprecise reduction of simple tibial plateau fractures. J Orthop Res 6:851-862, 1988.
17. Buckwalter JA: Osteoarthritis and articular cartilage use, disuse, and abuse: Experimental studies. J Rheumatol 43:13-15, 1995.
18. Burton-Wurster N, Vernier-Singer M, Farquhar T, Lust G: Effect of compressive loading and unloading on the synthesis of total protein, proteoglycan, and fibronectin by canine cartilage explants. J Orthop Res 11:717-729, 1993.
19. Carlson CS, Guilak F, Vail TP, Gardin JF, Kraus VB: Synovial fluid biomarker levels predict articular cartilage damage following complete medial meniscectomy in the canine knee. J Orthop Res 20:92-100, 2002.
20. Carney SL, Billingham ME, Muir H, Sandy JD: Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis. J Orthop Res 2:201-206, 1984.
21. Cernanec J, Guilak F, Weinberg JB, Pisetsky DS, Fermor B: Influence of hypoxia and reoxygenation on cytokine-induced production of proinflammatory mediators in articular cartilage. Arthritis Rheum 46:968-975, 2002.
22. Chandrasekharan NV, Dai H, Roos KL, et al: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci U S A 99:13926-13931, 2002.
23. Chen C-T, Burton-Wurster N, Borden C, et al: Chondrocyte necrosis and apoptosis in impact damaged articular cartilage. J Orthop Res 19:703-711, 2001.
24. Clancy RM, Amin AR, Abramson SB: The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141-1151, 1998.
25. Crofford LJ, Wilder RL, Ristimaki AP, et al: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: Effects of interleukin-1beta, phorbol ester, and corticosteroids. J Clin Inv 93:1095-1101, 1994.
26. Cryer B, Dubois A: The advent of highly selective inhibitors of cyclooxygenase: A review. Prostaglandins Other Lipid Mediat 56:341-361, 1998.
27. D'Lima DD, Hashimoto S, Chen PC, Colwell Jr CW, Lotz MK: Human chondrocyte apoptosis in response to mechanical injury. Osteoarthritis Cartilage 9:712-719, 2001.
28. Das P, Schurman DJ, Smith RL: Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear. J Orthop Res 15:87-93, 1997.
29. Das UN: Is obesity an inflammatory condition? Nutrition 17:953-966, 2001.
30. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW: The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 2:335-357, 1984.
31. Di Battista JA, Dore S, Martel-Pelletier J, Pelletier JP: Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: Identification of an effector autocrine loop involving insulin-like growth factor 1. Mol Cell Endocrinol 123:27-35, 1996.
32. Di Battista JA, Martel-Pelletier J, Fujimoto N, et al: Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts: Mediation by cyclic-AMP signalling pathway. Lab Invest 71:270-278, 1994.
33. Dingle J: Cartilage maintenance in osteoarthritis: Interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J Rheumatol Suppl 28:30-37, 1991.
34. Donohue JM, Buss D, Oegema Jr TR, Thompson Jr RC: The effects of indirect blunt trauma on adult canine articular cartilage. J Bone Joint Surg 65A:948-957, 1983.
35. Elliott DM, Guilak F, Vail TP, Wang JY, Setton LA: Tensile properties of articular cartilage are altered by meniscectomy in a canine model of osteoarthritis. J Orthop Res 17:503-508, 1999.
36. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C: Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 44:423-433, 1995.
37. Evans CH, Ghivizzani SC, Robbins PD: Blocking cytokines with genes. J Leukoc Biol 64:55-61, 1998.
38. Evans CH, Stefanovic-Racic M, Lancaster Jr JR. Nitric oxide and its role in orthopaedic disease. Clin Orthop 312:275-294, 1995.
39. Eyre DR, McDevitt CA, Billingham ME, Muir H: Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 188:823-837, 1980.
40. Farquhar T, Xia Y, Mann K, et al: Swelling and fibronectin accumulation in articular cartilage explants after cyclical impact. J Orthop Res 14:417-423, 1996.
41. Felson DT, Chaisson CE: Understanding the relationship between body weight and osteoarthritis. Baill Clin Rheum 11:671-681, 1997.
42. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ: Weight loss reduces the risk for symptomatic knee osteoarthritis in women: The Framingham Study. Ann Intern Med 116:535-539, 1992.
43. Fermor B, Haribabu B, Brice Weinberg J, Pisetsky DS, Guilak F: Mechanical stress and nitric oxide influence leukotriene production in cartilage, Biochem Biophys Res Commun 285:806-810, 2001.
44. Fermor B, Weinberg JB, Pisetsky DS, et al: The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res 19:729-737, 2001.
45. Fermor B, Weinberg JB, Pisetsky DS, et al: Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway. Osteoarthritis Cartilage 10:792-798, 2002.
46. Fernandes JC, Martel-Pelletier J, Pelletier JP: The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237-246, 2002.
47. Gebhard F, Pfetsch H, Steinbach G, et al: Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 135:291-295, 2000.
48. Geng Y, Blanco FJ, Cornelisson M, Lotz M: Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 155:796-801, 1995.
49. Gerstenfeld LC, Thiede M, Seibert K, et al: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 21:670-675, 2003.
50. Gilbertson EMM: Development of periarticular osteophytes in experimentally induced osteoarthrosis in the dog. Ann Rheum Dis 34:12-25, 1975.
51. Goldring MB, Suen LF, Yamin R, Lai WF: Regulation of collagen gene expression by prostaglandins and interleukin-1beta in cultured chondrocytes and fibroblasts. Am J Ther 3:9-16, 1996.
52. Goldring MB: Osteoarthritis and cartilage: The role of cytokines. Curr Rheumatol Rep 2:459-465, 2000.
53. Grabowski PS, Wright PK, Vanthof RJ, et al: Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 36:651-655, 1997.
54. Gray ML, Pizzanelli AM, Grodzinsky AJ, Lee RC: Mechanical and physiochemical determinants of the chondrocyte biosynthetic response. J Orthop Res 6:777-792, 1988.
55. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro: Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585-592, 1989.
56. Guilak F: Compression-induced changes in the shape and volume of the chondrocyte nucleus. J Biomech 28:1529-1542, 1995.
57. Guilak F, Meyer BC, Ratcliffe A, Mow VC: The effects of matrix compression on proteoglycan metabolism in articular cartilage explants. Osteoarthritis Cartilage 2:91-101, 1994.
58. Guilak F, Mow VC: The mechanical environment of the chondrocyte: A biphasic finite element model of cell-matrix interactions in articular cartilage. J Biomech 33:1663-1673, 2000.
59. Guilak F, Ratcliffe A, Lane N, Rosenwasser MP, Mow VC: Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritis. J Orthop Res 12:474-484, 1994.
60. Guilak F, Sah RL, Setton LA: Physical Regulation of Cartilage Metabolism. In Eds V. C. Mow, and W. C. Hayes (eds) Basic Orthopaedic Biomechanics. Philadelphia, Lippincott-Raven 179-207, 1997.
61. Harris ED: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990.
62. Hashimoto S, Takahashi K, Ochs RL, et al: Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum 42:2123-2131, 1999.
63. Hecke F, Schmidt U, Kola A, et al: Circulating complement proteins in multiple trauma patients: Correlation with injury severity, development of sepsis, and outcome. Crit Care Med 25:2015-2024, 1997.
64. Helminen HJ, Jurvelin J, Kiviranta I, et al: Joint Loading Effects on Articular Cartilage: A Historical Review. In Helminen HJ, Kiviranta I, Tammi M, et al (eds). Joint Loading: Biology and Health of Articular Structures. Bristol, Wright and Sons 1-46, 1987.
65. Hoch DH, Grodzinsky AJ, Koob TJ, Albert ML, Eyre DR: Early changes in material properties of rabbit articular cartilage after meniscectomy. J Orthop Res 1:4-12, 1983.
66. Holzheimer RG, Steinmetz W: Local and systemic concentrations of pro- and anti-inflammatory cytokines in human wounds. Eur J Med Res 5:347-355, 2000.
67. Hooiveld M, Roosendaal G, Wenting M, et al: Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 162:943-951, 2003.
68. Howell DS, Treadwell BV, Trippel SB: Etiopathogenesis of Osteoarthritis. In Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, (eds). Osteoarthritis: Diagnosis and Medical/Surgical Management. Philadelphia, W.B. Saunders 233-252, 1992.
69. Hughes FJ, Buttery LD, Hukkanen MV, et al: Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274:1776-1782, 1999.
70. Irie K, Uchiyama E, Iwaso H: Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 10:93-96, 2003.
71. Jang D, Murrell GAC: Nitric oxide in arthritis. Free Radic Biol Med 24:1511-1519, 1998.
72. Jeffrey JE, Gregory DW, Aspden RM: Matrix damage and chondrocyte viability following a single impact load on articular cartilage. Arch Biochem Biophys 322:87-96, 1995.
73. Jeffrey JE, Thomson LA, Aspden RM: Matrix loss and synthesis following a single impact load on articular cartilage in vitro. Biochim Biophys Acta 1334:223-232, 1997.
74. Kim YJ, Sah RL, Grodzinsky AJ, Plaas AH, Sandy JD: Mechanical regulation of cartilage biosynthetic behavior: Physical stimuli. Arch Biochem Biophys 311:1-12, 1994.
75. Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 137:3189-3194, 1986.
76. Konrath GA, Hamel AJ, Guerin J, et al: Biomechanical evaluation of impaction fractures of the femoral head. J Orthop Trauma 13:407-413, 1999.
77. Kraus V: COX-2 Inhibitors and non-steroidal anti-inflammatory drugs in the management of arthritis. Foot Ankle Clin 8:187-200, 2003.
78. Kraus VB: Pathogenesis and treatment of osteoarthritis. Med Clin North Am 81:85-112, 1997.
79. Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC: Articular cartilage and osteoarthritis. Raven Press, New York, 1992.
80. Lane NE: Physical activity at leisure and risk of osteoarthritis. Ann Rheum Dis 55:682-684, 1996.
81. Lee DA, Frean SP, Lees P, Bader DL: Dynamic mechanical compression influences nitric oxide production by articular chondrocytes seeded in agarose. Biochem Biophys Res Commun 251:580-585, 1998.
82. Lefkoe TP, Trafton PG, Ehrlich MG, et al: An experimental model of femoral condylar defect leading to osteoarthrosis. J Orthop Trauma 7:458-467, 1993.
83. Lefkoe TP, Walsh WR, Anastasatos J, Ehrlich MG, Barrach HJ: Remodeling of articular step-offs: Is osteoarthrosis dependent on defect size? Clin Orthop 314:253-265, 1995.
84. LeGrand A, Fermor B, Fink C, et al: Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E-2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum 44:2078-2083, 2001.
85. Lindhorst E, Vail TP, Guilak F, et al: Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis. J Orthop Res 18:269-280, 2000.
86. Loening AM, James IE, Levenston ME, et al: Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis. Arch Biochem Biophys 381:205-212, 2000.
87. Lovasz G, Park SH, Ebramzadeh E, et al: Characteristics of degeneration in an unstable knee with a coronal surface step-off. J Bone Joint Surg 83B:428-436, 2001.
88. Lucchinetti E, Adams CS, Horton Jr WE, Torzilli PA: Cartilage viability after repetitive loading: A preliminary report. Osteoarthritis Cartilage 10:71-81, 2002.
89. Lukoschek M, Boyd RD, Schaffler MB, Burr DB, Radin EL: Comparison of joint degeneration models. Surgical instability and repetitive impulsive loading. Acta Orthop Scand 57:349-353, 1986.
90. Lyngberg K, Danneskiold-Samsoe B, Halskov O: The effect of physical training on patients with rheumatoid arthritis: changes in disease activity, muscle strength and aerobic capacity: A clinically controlled minimized cross-over study. Clin Exp Rheum 6:253-260, 1988.
91. Lyons-Giordano B, Pratta M, Galbraith W, Davis G, Arner E: Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2. Exp Cell Res 206:58-62, 1993.
92. Marotta P, Sautebin L, Di Rosa M: Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107:640-641, 1992.
93. Marsh JL, Buckwalter J, Gelberman R, et al: Articular fractures: Does an anatomic reduction really change the result? J Bone Joint Surg 84A: 1259-1271, 2002.
94. Martel-Pelletier J, Alaaeddine N, Pelletier JP: Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 4:D694-D703, 1999.
95. McDevitt CA, Muir H: Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog. J Bone Joint Surg 58B:94-101, 1976.
96. Messier SP: Osteoarthritis of the knee and associated factors of age and obesity: Effects on gait. Med Sci Sports Exerc 26:1446-1452, 1994.
97. Messier SP, Loeser RF, Mitchell MN, et al: Exercise and weight loss in obese older adults with knee osteoarthritis: A preliminary study. J Am Geriatr Soc 48:1062-1072, 2000.
98. Milano S, Arcoleo F, Dieli M, et al: Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49:105-115, 1995.
99. Mohtai M, Gupta MK, Donlon B, et al: Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. J Orthop Res 14:67-73, 1996.
100. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993.
101. Moskowitz RW, Davis W, Sammarco J: Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum 16:397-405, 1973.
102. Mow VC, Ratcliffe A, Poole AR: Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 13:67-97, 1992.
103. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
104. Neuberger GB: Press AN, Lindsley HB, et al: Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. Res Nurs Health 20:195-204, 1997.
105. Newberry WN, Mackenzie CD, Haut RC: Blunt impact causes changes in bone and cartilage in a regularly exercised animal model. J Orthop Res 16:348-354, 1998.
106. Nietfeld JJ, Wilbrink B, Helle M, et al: Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis Rheum 33:1695-1701, 1990.
107. Oegema Jr TR, Lewis JL, Thompson Jr RC: Role of acute trauma in development of osteoarthritis. Agents Actions 40:220-223, 1993.
108. Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM: Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology 10:161-166, 1999.
109. Olson SA, Bay BK, Chapman MW, Sharkey NA: Biomechanical consequences of fracture and repair of the posterior wall of the acetabulum. J Bone Joint Surg 77A:1184-1192, 1995.
110. Olson SA, Bay BK, Pollak AN, Sharkey NA, Lee T: The effect of variable size posterior wall acetabular fractures on contact characteristics of the hip joint. J Orthop Trauma 10:395-402, 1996.
111. Palmoski MJ, Brandt KD: Effects of static and cyclic compressive loading on articular cartilage plugs in vitro. Arthritis Rheum 27:675-681, 1984.
112. Pape HC, van Griensven M, Rice J, et al: Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: Determination of the clinical relevance of biochemical markers. J Trauma 50:989-1000, 2001.
113. Pelletier JP, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 19:545-568, 1993.
114. Pelletier JP, Jovanovic D, Fernandes JC, et al: Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41:1275-1286, 1998.
115. Penning TD, Talley JJ, Bertenshaw SR, et al: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benze nesulfonamide (SC-58635, celecoxib). J Med Chem 40:1347-1365, 1997.
116. Perl M, Gebhard F, Knoferl MW, et al: The pattern of preformed cytokines in tissues frequently affected by blunt trauma. Shock 19:299-304, 2003.
117. Pickvance EA, Oegema Jr TR, Thompson Jr RC: Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J Orthop Res 11:313-323, 1993.
118. Pond MJ, Nuki G: Experimentally induced osteoarthritis in the dog. Ann Rheum Dis 32:387-388, 1973.
119. Quinn TM, Allen RG, Schalet BJ, Perumbuli P, Hunziker EB: Matrix and cell injury due to sub-impact loading of adult bovine articular cartilage explants: Effects of strain rate and peak stress. J Orthop Res 19:242-249, 2001.
120. Quinn TM, Grodzinsky AJ, Hunziker EB, Sandy JD: Effects of injurious compression on matrix turnover around individual cells in calf articular cartilage explants. J Orthop Res 16:490-499, 1998.
121. Radin EL: Protest the continuing common usage of the term osteoarthritis. Clin Orthop 263:310-312, 1990.
122. Radin EL, Martin RB, Burr DB, et al: Effects of mechanical loading on the tissues of the rabbit knee. J Orthop Res 2:221-234, 1984.
123. Ragan PM, Badger AM, Cook M, et al: Down-regulation of chondrocyte aggrecan and type-II collagen gene expression correlates with increases in static compression magnitude and duration. J Orthop Res 17:836-842, 1999.
124. Rall LC, Meydani SN, Kehayias JJ, Dawson-Hughes B, Roubenoff R: The effect of progressive resistance training in rheumatoid arthritis: Increased strength without changes in energy balance or body composition. Arthritis Rheum 39:415-426, 1996.
125. Ratcliffe A, Billingham ME, Saed-Nejad F, Muir H, Hardingham TE: Increased release of matrix components from articular cartilage in experimental canine osteoarthritis. J Orthop Res 10:350-358, 1992.
126. Roos H, Lauren M, Adalberth T, et al: Knee osteoarthritis after meniscectomy: Prevalence of radiographic changes after twenty-one years, compared with matched controls. Arthritis Rheum 41:687-693, 1998.
127. Rowan AD, Koshy PJ, Shingleton WD, et al: Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 44:1620-1632, 2001.
128. Sah RL, Kim YJ, Doong JY, et al: Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res 7:619-636, 1989.
129. Salvemini D, Manning PT, Zweifel BS, et al: Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96:301-308, 1995.
130. Salvemini D, Misko TP, Masferrer JL, et al: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90:7240-7244, 1993.
131. Sandy JD, Adams ME, Billingham ME, Plaas A, Muir H: In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum 27:388-397, 1984.
132. Schwartz MH, Leo PH, Lewis JL: A microstructural model for the elastic response of articular cartilage. J Biomech 27:865-873, 1994.
133. Setton LA, Mow VC, Muller FJ, Pita JC, Howell DS: Mechanical properties of canine articular cartilage are significantly altered following transection of the anterior cruciate ligament. J Orthop Res 12:451-463, 1994.
134. Sharma L: Local factors in osteoarthritis. Curr Opin Rheumatol 13:441-446, 2001.
135. Shay AK, Bliven ML, Scampoli DN, Otterness IG, Milici AJ: Effects of exercise on synovium and cartilage from normal and inflamed knees. Rheumatol Int 14:183-189, 1995.
136. Shephard RJ, Shek PN: Autoimmune disorders, physical activity, and training, with particular reference to rheumatoid arthritis. Exercise Immunol Rev 3:53-67, 1997.
137. Shinoda C, Takaku S: Interleukin-1 beta, interleukin-6, and tissue inhibitor of metalloproteinase-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction. Oral Dis 6:383-390, 2000.
138. Smith RD, Polley HF: Rest therapy for rheumatoid arthritis. Mayo Clin Proc 53:141-145, 1978.
139. Smith RL, Donlon BS, Gupta MK, et al: Effects of fluid-induced shear on articular chondrocyte morphology and metabolism in vitro. J Orthop Res 13:824-831, 1995.
140. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902, 1992.
141. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH: Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 21:1892-1898, 1994.
142. Strecker W, Gebhard F, Rager J, et al: Early biochemical characterization of soft-tissue trauma and fracture trauma. J Trauma 47:358-364, 1999.
143. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH: Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 7:377-379, 1999.
144. Thompson Jr RC, Oegema Jr TR, Lewis JL, Wallace L: Osteoarthrotic changes after acute transarticular load: An animal model. J Bone Joint Surg 73A:990-1001, 1991.
145. Torzilli PA, Grigiene R: Continuous cyclic load reduces proteoglycan release from articular cartilage. Osteoarthritis Cartilage 6:260-268, 1998.
146. Torzilli PA, Grigiene R, Borrelli Jr J, Helfet DL: Effect of impact load on articular cartilage: Cell metabolism and viability, and matrix water content. J Biomech Eng 121:433-441, 1999.
147. Torzilli PA, Tehrany AM, Grigiene R, Young E: Effects of misoprostol and prostaglandin E2 on proteoglycan biosynthesis and loss in unloaded and loaded articular cartilage explants. Prostaglandins 52:157-173, 1996.
148. Van De Loo A, Van Den Berg W: Effects of murine recombinant ILI on synovial joints in mice: Measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 49:238-245, 1990.
149. van den Berg WB: Lessons for joint destruction from animal models. Curr Opin Rheumatol 9:221-228, 1997.
150. van den Berg WB, Joosten LA, van de Loo FA: TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheum 17:S105-S114, 1999.
151. Vane JR, Botting RM: Mechanism of action of antiinflammatory drugs. Int J Tissue React 20:3-15, 1998.
152. Vane JR, Mitchell JA, Appleton I, et al: Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 91:2046-2050, 1994.
153. Vanwanseele B, Eckstein F, Knecht H, Spaepen A, Stussi E: Longitudinal analysis of cartilage atrophy in the knees of patients with spinal cord injury. Arthritis Rheum 48:3377-3381, 2003.
154. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135, 1999.
155. Warner TD, Giuliano F, Vojnovic I, et al: Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci U S A 96:7563-7568, 1999.
156. Westacott CI, Sharif M: Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25:254-272, 1996.
157. Ytterberg SR, Mahowald ML, Krug HE: Exercise for arthritis. Baill Clin Rheum 8:161-189, 1994.
158. Zhang X, Schwarz EM, Young DA, et al: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415, 2002.